Drug details

Osmolex ER (amantadine)

type of Antiparkinson Agents, Dopamine Agonists, Antivirals, Influenza

Osmolex ER (amantadine extended-release tablets) is indicated for the treatment of drug-induced extrapyramidal reactions in adult patients with Parkinson's disease.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• lightheadedness,
• shortness of breath,
• confusion,
• seizure,
• sweating,
• agitation,
• painful or difficult urination,
• swelling in your hands or feet,
• aggression,
• very stiff (rigid) muscles,
• high fever,
• fast or uneven heartbeats,
• depression,
• tremor,
• hallucinations,
• extreme drowsiness,
• falling asleep suddenly even after feeling alert,
• behavior changes,
• throughs of self-harm,
• increased sexual urges, and
• unusual urges to gamble, or other intense urges

The following drugs are related to Osmolex ER, either as a replacement or used together:

• Kynmobi (apomorphine hydrochloride sublingual film)
• Fluorodopa FDOPA (f18 injection)
• Nourianz (istradefylline tablets)